PNC Financial Services Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

PNC Financial Services Group’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-208	Closed	-$4K	–	4716
2021 Q3	$4K	Buy	208 +164	+373%	+$4.53K	﹤0.01%	4022
2021 Q2	$2K	Buy	+44	New	+$1.35K	﹤0.01%	4079

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

PNC Financial Services Group's DRNA Position: Q4 2021 in Review

PNC Financial Services Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 208 shares — an estimated $4K sold.

PNC Financial Services Group first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $4K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

PNC Financial Services Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
PNC Financial Services Group sold 208 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $4K.
PNC Financial Services Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
PNC Financial Services Group's Dicerna Pharmaceuticals, Inc. position peaked at $4K in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on PNC Financial Services Group's 13F filing for Q4 2021, filed 11 Feb 2022.